218 related articles for article (PubMed ID: 12409994)
21. Chronic muscle pain induced by repeated acid Injection is reversed by spinally administered mu- and delta-, but not kappa-, opioid receptor agonists.
Sluka KA; Rohlwing JJ; Bussey RA; Eikenberry SA; Wilken JM
J Pharmacol Exp Ther; 2002 Sep; 302(3):1146-50. PubMed ID: 12183674
[TBL] [Abstract][Full Text] [Related]
22. Effects of mu, kappa, and delta opioid receptor agonists on the function of hypothalamic-pituitary-adrenal axis in monkeys.
Pascoe JE; Williams KL; Mukhopadhyay P; Rice KC; Woods JH; Ko MC
Psychoneuroendocrinology; 2008 May; 33(4):478-86. PubMed ID: 18325678
[TBL] [Abstract][Full Text] [Related]
23. Antinociceptive effects of the selective delta opioid agonist SNC80 alone and in combination with mu opioids in the squirrel monkey titration procedure.
Dykstra LA; Granger AL; Allen RM; Zhang X; Rice KC
Psychopharmacology (Berl); 2002 Oct; 163(3-4):420-9. PubMed ID: 12373443
[TBL] [Abstract][Full Text] [Related]
24. Dextromethorphan and ketamine potentiate the antinociceptive effects of mu- but not delta- or kappa-opioid agonists in a mouse model of acute pain.
Baker AK; Hoffmann VL; Meert TF
Pharmacol Biochem Behav; 2002 Dec; 74(1):73-86. PubMed ID: 12376154
[TBL] [Abstract][Full Text] [Related]
25. BU48: a novel buprenorphine analog that exhibits delta-opioid-mediated convulsions but not delta-opioid-mediated antinociception in mice.
Broom DC; Guo L; Coop A; Husbands SM; Lewis JW; Woods JH; Traynor JR
J Pharmacol Exp Ther; 2000 Sep; 294(3):1195-200. PubMed ID: 10945877
[TBL] [Abstract][Full Text] [Related]
26. Effects of kappa opioid agonists on the discriminative stimulus effects of cocaine in rhesus monkeys.
Negus SS; Mello NK
Exp Clin Psychopharmacol; 1999 Nov; 7(4):307-17. PubMed ID: 10609965
[TBL] [Abstract][Full Text] [Related]
27. Anti-nociception mediated by a κ opioid receptor agonist is blocked by a δ receptor agonist.
Taylor AM; Roberts KW; Pradhan AA; Akbari HA; Walwyn W; Lutfy K; Carroll FI; Cahill CM; Evans CJ
Br J Pharmacol; 2015 Jan; 172(2):691-703. PubMed ID: 24923251
[TBL] [Abstract][Full Text] [Related]
28. Assessment of the discriminative stimulus effects of cocaine in the rat: lack of interaction with opioids.
Broadbent J; Gaspard TM; Dworkin SI
Pharmacol Biochem Behav; 1995; 51(2-3):379-85. PubMed ID: 7667357
[TBL] [Abstract][Full Text] [Related]
29. Discriminative stimulus properties of U50,488 and morphine: effects of training dose on stimulus substitution patterns produced by mu and kappa opioid agonists.
Picker MJ; Doty P; Negus SS; Mattox SR; Dykstra LA
J Pharmacol Exp Ther; 1990 Jul; 254(1):13-22. PubMed ID: 2164087
[TBL] [Abstract][Full Text] [Related]
30. Opioid enhancement of the discriminative stimulus effects of cocaine: evidence for involvement of mu and delta opioid receptors.
Rowlett JK; Spealman RD
Psychopharmacology (Berl); 1998 Nov; 140(2):217-24. PubMed ID: 9860113
[TBL] [Abstract][Full Text] [Related]
31. The opioid receptor like-1 receptor agonist Ro 64-6198 (1S,3aS-8-2,3,3a,4,5,6-hexahydro-1H-phenalen-1-yl-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-one) produces a discriminative stimulus in rats distinct from that of a mu, kappa, and delta opioid receptor agonist cue.
Recker MD; Higgins GA
J Pharmacol Exp Ther; 2004 Nov; 311(2):652-8. PubMed ID: 15226383
[TBL] [Abstract][Full Text] [Related]
32. Role of delta opioid receptors in the reinforcing and discriminative stimulus effects of cocaine in rhesus monkeys.
Negus SS; Mello NK; Portoghese PS; Lukas SE; Mendelson JH
J Pharmacol Exp Ther; 1995 Jun; 273(3):1245-56. PubMed ID: 7791097
[TBL] [Abstract][Full Text] [Related]
33. Attenuation of the gerbil writhing response by mu-, kappa- and delta-opioids, and NK-1, -2 and -3 receptor antagonists.
Gallantine EL; Meert TF
Pharmacol Biochem Behav; 2004 Sep; 79(1):125-35. PubMed ID: 15388292
[TBL] [Abstract][Full Text] [Related]
34. Differential effects of micro-opioid, delta-opioid and kappa-opioid receptor agonists on dopamine receptor agonist-induced climbing behavior in mice.
Ito S; Mori T; Sawaguchi T
Behav Pharmacol; 2006 Dec; 17(8):691-701. PubMed ID: 17110795
[TBL] [Abstract][Full Text] [Related]
35. Interactions between mu and kappa opioid agonists in the rat drug discrimination procedure.
Negus SS; Picker MJ; Dykstra LA
Psychopharmacology (Berl); 1990; 102(4):465-73. PubMed ID: 1965748
[TBL] [Abstract][Full Text] [Related]
36. Opioid peptide receptor studies. 12. Buprenorphine is a potent and selective mu/kappa antagonist in the [35S]-GTP-gamma-S functional binding assay.
Romero DV; Partilla JS; Zheng QX; Heyliger SO; Ni Q; Rice KC; Lai J; Rothman RB
Synapse; 1999 Nov; 34(2):83-94. PubMed ID: 10502307
[TBL] [Abstract][Full Text] [Related]
37. Pharmacological characterization of buprenorphine, a mixed agonist-antagonist with kappa 3 analgesia.
Pick CG; Peter Y; Schreiber S; Weizman R
Brain Res; 1997 Jan; 744(1):41-6. PubMed ID: 9030411
[TBL] [Abstract][Full Text] [Related]
38. HS-599: a novel long acting opioid analgesic does not induce place-preference in rats.
Lattanzi R; Negri L; Giannini E; Schmidhammer H; Schutz J; Improta G
Br J Pharmacol; 2001 Sep; 134(2):441-7. PubMed ID: 11564664
[TBL] [Abstract][Full Text] [Related]
39. Buprenorphine antinociception is abolished, but naloxone-sensitive reward is retained, in mu-opioid receptor knockout mice.
Ide S; Minami M; Satoh M; Uhl GR; Sora I; Ikeda K
Neuropsychopharmacology; 2004 Sep; 29(9):1656-63. PubMed ID: 15100703
[TBL] [Abstract][Full Text] [Related]
40. Discriminative stimulus effects of butorphanol: influence of training dose on the substitution patterns produced by Mu, Kappa and Delta opioid agonists.
Picker MJ; Benyas S; Horwitz JA; Thompson K; Mathewson C; Smith MA
J Pharmacol Exp Ther; 1996 Dec; 279(3):1130-41. PubMed ID: 8968334
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
